Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 53.54% | $4.91B | 0.35% |
GNOM | 51.11% | $49.81M | 0.5% |
ARKG | 49.99% | $967.16M | 0.75% |
IBB | 49.44% | $5.38B | 0.45% |
IWC | 48.55% | $760.52M | 0.6% |
PTH | 47.30% | $104.86M | 0.6% |
PBE | 46.97% | $219.45M | 0.58% |
XPH | 43.41% | $143.84M | 0.35% |
BBH | 42.95% | $340.74M | 0.35% |
FBT | 42.52% | $1.05B | 0.56% |
IWO | 42.49% | $10.76B | 0.24% |
ARKK | 42.39% | $5.23B | 0.75% |
VTWO | 42.16% | $11.11B | 0.07% |
IWM | 42.07% | $58.62B | 0.19% |
KOMP | 41.98% | $2.00B | 0.2% |
CPRJ | 41.28% | $47.24M | 0.69% |
KJUL | 41.16% | $112.16M | 0.79% |
KAPR | 40.95% | $182.00M | 0.79% |
PINK | 40.85% | $138.96M | 0.5% |
SCHA | 40.42% | $15.65B | 0.04% |
Yahoo
Q4 2024 Celcuity Inc Earnings Call
Yahoo
MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that Brian Sullivan, Chief Executive Officer, and Co-founder of Celcuity, will present and be available for one-on-one investor meetings at the following investor conferences: A fireside chat at the Stifel 2025 Virtual Targeted Oncology Forum at 10:00 a.m. ET on Wednesday, April 9, 2025. A live webcast will b
Yahoo
Despite a significant net loss, Celcuity Inc (CELC) advances its clinical trials and maintains a strong cash position to support future growth.
SeekingAlpha
The following slide deck was published by Celcuity Inc.
SeekingAlpha
Celcuity Inc. (NASDAQ:CELC) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ETCompany ParticipantsApoorva Chaloori - ICR Healthcare, Investor...
Yahoo
The PIK3CA wild-type cohort of the VIKTORIA-1 Phase 3 trial is on track to report topline data in Q2 2025VIKTORIA-2 Phase 3 remains on track to enroll its first patient in Q2 2025Presented encouraging preliminary overall survival data from the Phase 1b study evaluating gedatolisib in combination with palbociclib and endocrine therapy at the 2024 SABCSApproximately $235.1 million in cash, cash equivalents and short-term investments at end of Q4 2024 expected to fund current clinical development p
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IEF | 0.02% | $34.49B | 0.15% |
GOVT | -0.03% | $27.18B | 0.05% |
IBTK | 0.05% | $428.81M | 0.07% |
VGIT | -0.06% | $31.78B | 0.04% |
MINO | -0.08% | $293.04M | 0.39% |
USFR | -0.15% | $18.68B | 0.15% |
UTEN | 0.16% | $191.19M | 0.15% |
TDTT | 0.16% | $2.38B | 0.18% |
TYA | 0.16% | $162.71M | 0.15% |
SOYB | 0.20% | $25.13M | 0.22% |
IBTG | -0.24% | $1.85B | 0.07% |
ZROZ | -0.24% | $1.46B | 0.15% |
UNG | -0.25% | $457.33M | 1.06% |
JMUB | 0.27% | $2.69B | 0.18% |
TBLL | -0.29% | $2.52B | 0.08% |
NUBD | -0.29% | $400.67M | 0.16% |
EDV | -0.33% | $3.43B | 0.05% |
TAXF | -0.40% | $501.77M | 0.29% |
IBTH | 0.41% | $1.50B | 0.07% |
VGLT | 0.42% | $9.77B | 0.04% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
THG | 0.13% | $5.87B | +25.10% | 2.15% |
CF | -0.17% | $13.26B | -1.47% | 2.52% |
COKE | -0.21% | $11.79B | +62.14% | 0.59% |
DUK | 0.22% | $93.76B | +22.22% | 3.44% |
VZ | 0.29% | $178.89B | +5.74% | 6.32% |
PULM | -0.41% | $23.76M | +242.33% | 0.00% |
AEP | -0.46% | $59.58B | +23.53% | 3.37% |
AHCO | -0.47% | $1.10B | -19.45% | 0.00% |
CLX | 0.51% | $17.10B | -6.81% | 3.49% |
WRB | 0.56% | $26.81B | +39.64% | 0.51% |
ACHC | 0.63% | $2.04B | -70.27% | 0.00% |
EXC | -0.65% | $46.92B | +23.22% | 3.31% |
ZBH | -0.70% | $20.13B | -16.39% | 0.94% |
TKC | 0.74% | $5.25B | -0.33% | 3.41% |
SIGI | -0.74% | $5.30B | -14.02% | 1.67% |
ENSG | 0.88% | $7.30B | +7.06% | 0.19% |
DESP | -0.93% | $1.62B | +53.23% | 0.00% |
KO | 0.94% | $308.95B | +15.72% | 2.74% |
DSP | 0.96% | $903.07M | +69.35% | 0.00% |
PGR | -0.98% | $158.04B | +30.44% | 1.79% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -33.95% | $195.31M | 0.85% |
BTAL | -32.30% | $442.21M | 1.43% |
TAIL | -28.58% | $153.24M | 0.59% |
SHYM | -13.24% | $308.82M | 0.35% |
BSMW | -12.42% | $101.64M | 0.18% |
USDU | -12.14% | $197.29M | 0.5% |
UUP | -10.34% | $284.19M | 0.77% |
JMST | -10.17% | $3.46B | 0.18% |
CTA | -9.60% | $1.02B | 0.76% |
FTSD | -9.37% | $220.14M | 0.25% |
IVOL | -9.16% | $314.13M | 1.02% |
CGSM | -9.11% | $652.77M | 0.25% |
SHYD | -8.85% | $316.83M | 0.35% |
DFNM | -8.64% | $1.52B | 0.17% |
FMHI | -7.34% | $728.23M | 0.7% |
MMIT | -7.29% | $825.03M | 0.3% |
BUXX | -6.88% | $275.04M | 0.25% |
AGZ | -6.83% | $612.24M | 0.2% |
IBMS | -5.86% | $55.11M | 0.18% |
XONE | -5.73% | $603.26M | 0.03% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -18.19% | $61.83M | -99.91% | 0.00% |
CHD | -16.04% | $24.32B | -7.58% | 1.16% |
CBOE | -13.88% | $22.22B | +17.62% | 1.14% |
NOC | -13.81% | $69.56B | -0.60% | 1.71% |
MCK | -8.73% | $87.69B | +30.52% | 0.39% |
VSTA | -7.96% | $385.77M | +26.91% | 0.00% |
VHC | -6.96% | $36.50M | +59.76% | 0.00% |
ED | -6.36% | $40.03B | +18.26% | 3.00% |
LFVN | -6.14% | $152.37M | +102.00% | 1.29% |
BNED | -5.89% | $353.14M | -48.15% | 0.00% |
CL | -5.40% | $73.78B | +0.52% | 2.20% |
COR | -5.13% | $55.80B | +19.93% | 0.73% |
LITB | -4.94% | $27.71M | -64.39% | 0.00% |
BTCT | -4.57% | $20.50M | +62.55% | 0.00% |
PRT | -4.46% | $48.66M | -3.61% | 11.32% |
CME | -4.05% | $96.55B | +27.81% | 3.90% |
RTX | -3.97% | $166.73B | +21.83% | 2.01% |
GHG | -3.92% | $138.24M | -35.51% | 0.00% |
CI | -2.72% | $90.77B | -6.07% | 1.70% |
K | -2.65% | $28.46B | +41.63% | 2.75% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CLDX | 46.81% | $1.42B | -42.27% | 0.00% |
RCKT | 45.63% | $763.47M | -67.23% | 0.00% |
ELVN | 45.45% | $926.67M | +6.30% | 0.00% |
XENE | 45.00% | $2.90B | -11.44% | 0.00% |
OCUL | 44.62% | $1.30B | +69.38% | 0.00% |
BEAM | 42.92% | $1.99B | -10.20% | 0.00% |
ATXS | 42.82% | $279.91M | -45.79% | 0.00% |
KYMR | 42.75% | $2.18B | -3.03% | 0.00% |
CRNX | 42.41% | $3.08B | -24.75% | 0.00% |
DNLI | 42.15% | $2.36B | +4.17% | 0.00% |
COGT | 41.58% | $559.03M | -26.83% | 0.00% |
IDYA | 41.53% | $1.73B | -51.41% | 0.00% |
RXRX | 40.93% | $2.35B | -28.78% | 0.00% |
IMNM | 40.69% | $746.04M | -37.92% | 0.00% |
NRIX | 39.21% | $874.42M | -8.02% | 0.00% |
VRDN | 38.83% | $1.10B | -0.51% | 0.00% |
CLNE | 38.81% | $331.47M | -39.34% | 0.00% |
LAW | 38.41% | $223.42M | -52.26% | 0.00% |
XPER | 38.34% | $335.47M | -31.31% | 0.00% |
STOK | 38.33% | $512.12M | -20.15% | 0.00% |
Current Value
$11.041 Year Return
Current Value
$11.041 Year Return